These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17188039)

  • 1. LXIII Edward Jackson Memorial Lecture: Eye care: dollars and sense.
    Taylor HR
    Am J Ophthalmol; 2007 Jan; 143(1):1-8. PubMed ID: 17188039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of interventions for visual impairment.
    Taylor HR; Pezzullo ML; Nesbitt SJ; Keeffe JE
    Am J Ophthalmol; 2007 Apr; 143(4):561-5. PubMed ID: 17222383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between vision loss and higher medical care costs in Medicare beneficiaries costs are greater for those with progressive vision loss.
    Javitt JC; Zhou Z; Willke RJ
    Ophthalmology; 2007 Feb; 114(2):238-45. PubMed ID: 17270673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic burden of vision loss and eye disorders among the United States population younger than 40 years.
    Wittenborn JS; Zhang X; Feagan CW; Crouse WL; Shrestha S; Kemper AR; Hoerger TJ; Saaddine JB;
    Ophthalmology; 2013 Sep; 120(9):1728-35. PubMed ID: 23631946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost of vision loss in Canada. 2. Results.
    Cruess AF; Gordon KD; Bellan L; Mitchell S; Pezzullo ML
    Can J Ophthalmol; 2011 Aug; 46(4):315-8. PubMed ID: 21816249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost of vision loss in Canada. 1. Methodology.
    Gordon KD; Cruess AF; Bellan L; Mitchell S; Pezzullo ML
    Can J Ophthalmol; 2011 Aug; 46(4):310-4. PubMed ID: 21816248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic impact and cost of visual impairment in Australia.
    Taylor HR; Pezzullo ML; Keeffe JE
    Br J Ophthalmol; 2006 Mar; 90(3):272-5. PubMed ID: 16488942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic impact of sight loss and blindness in the UK adult population.
    Pezzullo L; Streatfeild J; Simkiss P; Shickle D
    BMC Health Serv Res; 2018 Jan; 18(1):63. PubMed ID: 29382329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic impact of visual impairment and blindness in the United States.
    Frick KD; Gower EW; Kempen JH; Wolff JL
    Arch Ophthalmol; 2007 Apr; 125(4):544-50. PubMed ID: 17420375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost of care for people with impaired vision in Australia.
    Keeffe JE; Chou SL; Lamoureux EL
    Arch Ophthalmol; 2009 Oct; 127(10):1377-81. PubMed ID: 19822857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical care cost of Medicare/Medicaid beneficiaries with vision loss.
    Morse AR; Pyenson BS
    Ophthalmic Epidemiol; 2009; 16(1):50-7. PubMed ID: 19191182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic cost of visual impairment in Japan.
    Roberts CB; Hiratsuka Y; Yamada M; Pezzullo ML; Yates K; Takano S; Miyake K; Taylor HR
    Arch Ophthalmol; 2010 Jun; 128(6):766-71. PubMed ID: 20547955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The magnitude and cost of global blindness: an increasing problem that can be alleviated.
    Frick KD; Foster A
    Am J Ophthalmol; 2003 Apr; 135(4):471-6. PubMed ID: 12654362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The National Eye Survey of Trinidad and Tobago (NESTT): Rationale, Objectives and Methodology.
    Braithwaite T; Verlander NQ; Bartholomew D; Bridgemohan P; McNally K; Roach A; Sharma S; Singh D; Pesudovs K; Teelucksingh S; Carrington C; Ramsewak S; Bourne R;
    Ophthalmic Epidemiol; 2017 Apr; 24(2):116-129. PubMed ID: 28107088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonmedical economic consequences attributable to visual impairment: a nation-wide approach in France.
    Lafuma A; Brezin A; Fagnani F; Mimaud V; Mesbah M; Berdeaux G
    Eur J Health Econ; 2006 Sep; 7(3):158-64. PubMed ID: 16850334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Simple Method for Estimating the Economic Cost of Productivity Loss Due to Blindness and Moderate to Severe Visual Impairment.
    Eckert KA; Carter MJ; Lansingh VC; Wilson DA; Furtado JM; Frick KD; Resnikoff S
    Ophthalmic Epidemiol; 2015; 22(5):349-55. PubMed ID: 26395661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic impact of primary open-angle glaucoma in Australia.
    Dirani M; Crowston JG; Taylor PS; Moore PT; Rogers S; Pezzullo ML; Keeffe JE; Taylor HR
    Clin Exp Ophthalmol; 2011; 39(7):623-32. PubMed ID: 21631669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Economic Impact of Blindness in Europe.
    Chakravarthy U; Biundo E; Saka RO; Fasser C; Bourne R; Little JA
    Ophthalmic Epidemiol; 2017 Aug; 24(4):239-247. PubMed ID: 28665742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and burden of self-reported blindness, low vision, and visual impairment in the French community: a nationwide survey.
    Brézin AP; Lafuma A; Fagnani F; Mesbah M; Berdeaux G
    Arch Ophthalmol; 2005 Aug; 123(8):1117-24. PubMed ID: 16087847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current estimates of the economic burden of blindness and visual impairment in India: A cost of illness study.
    Mannava S; Borah RR; Shamanna BR
    Indian J Ophthalmol; 2022 Jun; 70(6):2141-2145. PubMed ID: 35648000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.